ES469016A1 - Un procedimiento para la preparacion de alfa1 timosina - Google Patents

Un procedimiento para la preparacion de alfa1 timosina

Info

Publication number
ES469016A1
ES469016A1 ES469016A ES469016A ES469016A1 ES 469016 A1 ES469016 A1 ES 469016A1 ES 469016 A ES469016 A ES 469016A ES 469016 A ES469016 A ES 469016A ES 469016 A1 ES469016 A1 ES 469016A1
Authority
ES
Spain
Prior art keywords
group
glu
formation
preparation
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469016A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES469016A1 publication Critical patent/ES469016A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57581Thymosin; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES469016A 1977-04-22 1978-04-21 Un procedimiento para la preparacion de alfa1 timosina Expired ES469016A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (1)

Publication Number Publication Date
ES469016A1 true ES469016A1 (es) 1980-01-01

Family

ID=27120967

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469016A Expired ES469016A1 (es) 1977-04-22 1978-04-21 Un procedimiento para la preparacion de alfa1 timosina

Country Status (18)

Country Link
JP (1) JPS53137914A (enrdf_load_stackoverflow)
AT (1) AT364470B (enrdf_load_stackoverflow)
CA (1) CA1113088A (enrdf_load_stackoverflow)
CH (3) CH641152A5 (enrdf_load_stackoverflow)
DE (1) DE2817082A1 (enrdf_load_stackoverflow)
DK (1) DK147918C (enrdf_load_stackoverflow)
ES (1) ES469016A1 (enrdf_load_stackoverflow)
FI (1) FI781241A7 (enrdf_load_stackoverflow)
FR (2) FR2401134A1 (enrdf_load_stackoverflow)
GB (1) GB1590668A (enrdf_load_stackoverflow)
GR (1) GR71886B (enrdf_load_stackoverflow)
HU (1) HU180783B (enrdf_load_stackoverflow)
IT (1) IT1113134B (enrdf_load_stackoverflow)
LU (1) LU79488A1 (enrdf_load_stackoverflow)
NL (1) NL7804364A (enrdf_load_stackoverflow)
NO (2) NO781404L (enrdf_load_stackoverflow)
PT (1) PT67937B (enrdf_load_stackoverflow)
SE (1) SE447262B (enrdf_load_stackoverflow)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α-1衍生物
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
CH640218A5 (en) 1983-12-30
DK169478A (da) 1978-10-23
DE2817082A1 (de) 1978-11-02
ATA286178A (de) 1981-03-15
HU180783B (en) 1983-04-29
NO148924B (no) 1983-10-03
SE447262B (sv) 1986-11-03
AT364470B (de) 1981-10-27
IT1113134B (it) 1986-01-20
DK147918B (da) 1985-01-07
PT67937B (en) 1980-04-07
FR2405926A1 (fr) 1979-05-11
CA1113088A (en) 1981-11-24
GB1590668A (en) 1981-06-03
PT67937A (en) 1978-05-01
NO821608L (no) 1978-10-24
DK147918C (da) 1985-08-19
CH641153A5 (en) 1984-02-15
FI781241A7 (fi) 1978-10-23
NL7804364A (nl) 1978-10-24
NO148924C (no) 1984-01-11
CH641152A5 (en) 1984-02-15
FR2405926B1 (enrdf_load_stackoverflow) 1983-09-09
LU79488A1 (de) 1979-05-25
SE7804612L (sv) 1978-12-20
FR2401134B1 (enrdf_load_stackoverflow) 1983-09-30
FR2401134A1 (fr) 1979-03-23
IT7822629A0 (it) 1978-04-21
GR71886B (enrdf_load_stackoverflow) 1983-08-04
JPS53137914A (en) 1978-12-01
NO781404L (no) 1978-10-24

Similar Documents

Publication Publication Date Title
KR850003417A (ko) 폴리펩티드의 제조방법
GB1487717A (en) Diagnostic agent for the detection of protein in body fluids
AU578722B2 (en) Fluid spacer composition for use in well cementing
PT1100529E (pt) A timosina beta 4 promove a preparacao de feridas
DE68905633D1 (de) Markierer der t-zelle aktivierung.
KR850008681A (ko) 합성펩티드의 제조방법
AR086483A2 (es) Vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para la deteccion de un polinucleotido, anticuerpo, metodo de empleo del anticuerpo, y uso para la manufactura de un medicamento para modular la fisiologia o el desarrollo de una celula o celulas de cultivo de tejido
GR900100513A (en) Reinforced compositions for the release of peptides soluble in water
DK576989D0 (da) Glasflusblanding til anvendelse i glaseringer eller emailler
DK0883687T3 (da) C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
GB1516947A (en) Hentricontapeptides
AU2453488A (en) Turbine blade with restored tip
DK0600992T3 (da) Anvendelse af gentissyre eller gentisylalkohol til stabilisering af radiomærkede peptider og proteiner
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
AU7565991A (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
ES469016A1 (es) Un procedimiento para la preparacion de alfa1 timosina
DE69018926D1 (de) Vakzine gegen Bordetella.
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
Luedke et al. Map showing distribution, composition, and age of Late Cenozoic volcanic centers in Oregon and Washington
AU659866B2 (en) Probe system for performing HLA DR typing and typing method using said probes
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
Nielsen Composition and origin of Wisconsinan till in mainland Nova Scotia
EP0317279A3 (en) Peptides for use in the purification of factor viii
JPS53132539A (en) Protected amino acid or peptide having said protected amino acid residue
Kumar et al. Phenomenon of crack branching

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991102